此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Tactile Breast Imaging Sensor for Tumor Malignancy Characterization

2019年5月31日 更新者:Temple University
The aim of this study is to see how well a tactile imaging sensor will detect for breast masses compared to traditional mammography and/or ultrasound. This device may allow a simple, convenient method to screen for breast tumors. This data will be used to check the feasibility of using the device to detect breast tumors.

研究概览

详细说明

The tactile imaging sensor will estimate the relative size and elasticity of the mass(es). This device may allow a simple, convenient method to screen for breast tumors. This is not a treatment and it will not be used to diagnose abnormal masses. The investigators will also not look for any unknown masses. And only doctors will touch the patients. An engineering assistant will be in the room to operate the tactile imaging sensor.

The breast scan that is done as part of this research protocol is not intended to detect any breast disease or abnormality. Research breast scans are not examined by a clinical radiologist to look for abnormalities. Research scan will be evaluated by the engineers developing the device to assess its usefulness. The breast scan for this research will only look at a portion of your breast as it relates to this research. The investigators, the tactile imaging sensor operators and other members of the research team are not qualified to interpret the scan for any diagnostic or therapeutic value. Therefore, the tactile imaging scan being done for this research study will not be analyzed to detect any medical condition.

Patients will have done mammography or ultrasound by now. Once the doctor decides to perform biopsy, the tactile imaging will be planned. The consent will be obtained before the biopsy. One of the investigators (Dr. Caroline or Dr. Reilly) will obtain the consent. Before the biopsy, the doctor will identify the mass(es) using other modalities such as a ultrasound. The tactile imaging sensor operator will obtain the tactile images. Then the biopsy will be performed. Radiology doctor, resident, and radiology technologist are always present during the procedure. In addition a professional assistant from the engineering group will operate the tactile imaging sensor. That person will not have any physical contact with you. The procedure will be very similar to the ultrasound device.

The images will be analyzed by the investigators.

研究类型

观察性的

注册 (实际的)

20

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

30年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

取样方法

非概率样本

研究人群

Women who had mammogram and are getting biopsy.

描述

Inclusion Criteria:

  • Women who had mammogram and/or ultrasound birads (category IV or V)
  • Women ages between 30 and 80.
  • Women who have been scheduled for biopsy from the Temple breast surgery clinic
  • Women who have been scheduled for biopsy by Dr. Kathleen Reilly.
  • Women, who speak and understand English.

Exclusion Criteria:

  • Women who do not meet the criteria requiring biopsy.
  • Women who have allergic reaction to silicone.
  • Women who cannot speak or understand English.
  • Women who are pregnant.
  • Women, younger than 30 years old, and older than 80 years old.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Women with Breast Tumors
Women with breast tumors.
This is a camera with elastomer tip and LED lights. It is a harmless device.
其他名称:
  • mechanical property estimation device
  • tactile sensor

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Size Error in Millimeters
大体时间:1 year
We obtain the image of the tumor and estimate its size. We compare this with the mammogram size data to compute the size error.
1 year

次要结果测量

结果测量
措施说明
大体时间
Malignancy Estimation Using Risk Score
大体时间:1 year

The tumor risk score is calculated from the tumor size and deformation index. The scale will be from 0 to 5. With 0 being likely to be benign and 5 being likely to be malignant.

We weigh the size 30% and deformation index 70% to come with the risk score. The tumor size is given in millimeters and deformation index is unitless.

Deformation Index represents the hardness of the tumor. The amount at which the probe tip gets deformed by applying a force is called deformation index.

Under the condition that the applied force, depth of the tumor and size of the tumor phantom are kept constant, the softer tumor makes the probe tip deform less than the stiffer tumor. Hence the deformation index for stiffer inclusion will be higher than the softer tumors.

1 year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2011年3月11日

初级完成 (实际的)

2017年10月11日

研究完成 (实际的)

2017年10月11日

研究注册日期

首次提交

2015年11月3日

首先提交符合 QC 标准的

2015年11月10日

首次发布 (估计)

2015年11月11日

研究记录更新

最后更新发布 (实际的)

2019年7月26日

上次提交的符合 QC 标准的更新

2019年5月31日

最后验证

2019年5月1日

更多信息

与本研究相关的术语

关键字

其他研究编号

  • 22050

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅